Suchergebnisse - "Ortega-Prieto, Ana Maria"

PubPharm (26)

1

Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections

enthalten in: bioRxiv.org | 2024

von Dupont, L. | Snell, L. | Graham, C. | +29

2

KCL TEST: an open-source inspired asymptomatic SARS-CoV-2 surveillance programme in an academic institution

enthalten in: bioRxiv.org | 2023

von Reis de Andrade, J. | Scourfield, E. | Peswani-Sajnani, S. | +34

3

Cross-Linking Mass Spectrometry Uncovers Interactions Between High-Density Lipoproteins and the SARS-CoV-2 Spike Glycoprotein

enthalten in: Molecular & cellular proteomics : MCP | 2023

von Burnap, S. | Ortega-Prieto, A. | Jimenez-Guardeño, J. | +7

4

Human Monkeypox : A Comprehensive Overview of Epidemiology, Pathogenesis, Diagnosis, Treatment, and Prevention Strategies

enthalten in: Pathogens (Basel, Switzerland) | 2023

von Martínez-Fernández, D. | Fernández-Quezada, D. | Casillas-Muñoz, F. | +4

5

Drug repurposing based on a Quantum-Inspired method versus classical fingerprinting uncovers potential antivirals against SARS-CoV-2 including vitamin B12

enthalten in: bioRxiv.org | 2023

von Jimenez-Guardeño, J. | Ortega-Prieto, A. | Moreno, B. | +9

6

Drug repurposing based on a quantum-inspired method versus classical fingerprinting uncovers potential antivirals against SARS-CoV-2

enthalten in: PLoS computational biology | 2022

von Jimenez-Guardeño, J. | Ortega-Prieto, A. | Menendez Moreno, B. | +9

UpdateOf: bioRxiv. 2021 Aug 10;:. - PMID 34401881

7

Guanosine inhibits hepatitis C virus replication and increases indel frequencies, associated with altered intracellular nucleotide pools

enthalten in: PLoS pathogens | 2022

von Sabariegos, R. | Ortega-Prieto, A. | Díaz-Martínez, L. | +10

8

Pluripotent Stem Cell-Derived Hepatocytes Inhibit T Cell Proliferation In Vitro through Tryptophan Starvation

enthalten in: Cells | 2021

von Romano, M. | Elgueta, R. | McCluskey, D. | +10

9

Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern

enthalten in: Nature microbiology | 2021

von Dupont, L. | Snell, L. | Graham, C. | +29

UpdateOf: medRxiv. 2021 Jun 08;:. - PMID 34127977

10

An Overview of Vaccines against SARS-CoV-2 in the COVID-19 Pandemic Era

enthalten in: Pathogens (Basel, Switzerland) | 2021

von Pascual-Iglesias, A. | Canton, J. | Ortega-Prieto, A. | +2